Urology

A propensity-weighted study compares micro-ultrasound with MRI fusion biopsy for detecting clinically significant prostate cancer in men with MRI-visible lesions.

Urinary cell-free microRNAs may enable non-invasive detection of aggressive bladder cancer subtypes, offering a rapid alternative to tissue-based molecular profiling.

Early urine output patterns in female ICU patients with genitourinary infections are strongly linked to 28-day mortality and acute kidney injury risk.

A 12-year follow-up study shows urinary symptoms worsen over time after vaginal delivery, but long-term severity and quality-of-life impact are similar with or without OASIS.

PSA derivatives may help reduce unnecessary prostate MRI in men with prior negative biopsy, while maintaining detection of clinically significant cancer.

SGLT2 inhibitors may slow prostate cancer progression in men on hormone therapy, reducing therapy failure. Find out how these diabetes drugs could help.

A new meta-analysis links elevated neutrophil-to-lymphocyte ratio to higher risk and progression of diabetic nephropathy, highlighting its potential as a clinical biomarker.

Plasma presepsin outperformed traditional biomarkers in predicting 28-day mortality among patients with UTI-related severe infection in emergency care.